학술논문
Mucormycosis after CD19 chimeric antigen receptor T-cell therapy: results of a US Food and Drug Administration adverse events reporting system analysis and a review of the literature
Document Type
Review Article
Author
Source
In The Lancet Infectious Diseases April 2024 24(4):e256-e265
Subject
Language
ISSN
1473-3099